After Hours Summary: MG +13.1%, EXFO +8.8%, RECN +4.9%, PODD -7.9%, WDFC -5.2% following earnings/guidance
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings: MG +13.1%, EXFO +8.8%, RECN +4.9%, ZUMZ +2.7%, XEL +1.4%
Companies trading higher in after hours in reaction to news: BIOD +29.7% (announced positive preliminary results from Study 3-151; data demonstrate That BIOD-531 provides superior glucose control compared to Humalog Mix 75/25 and Humulin R U-500), BIND +26.2% (provided clinical update for BIND-014 and 2015 strategic overview; co achieved development milestone as part of the Pfizer collaboration), NRX +19.3% (received positive Scientific Advice from the European Medicines Agency regarding their Phase 3 program with Pyridorin in diabetic nephropathy), VLCCF +14.5% (announced entry into an agreement with RWE Supply & Trading for chartering out a total of 15 Capesize vessels on long term contracts), RARE +7.3% (announced license of intellectual property related to the treatment of Huntington's Disease with Triheptanoin), MERU +3.1% (Vertex Special Opportunities Fund files amended 13D; believes retention of Deutsche Bank was a step in the right direction), BALT +1.4% (co entered into new $148 mln credit facility; co has taken delivery of the Baltic Wasp, a 64,000 dwt Ultramax newbuilding)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: PODD -7.9%, WDFC -5.2%
Companies trading lower in after hours in reaction to news: ALXN -4.8% (reported results from Phase 2 clinical trial to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection; primary composite endpoint did not reach statistical significance), AFSI -3.7% (announced the commencement of public offering of 3 mln shares common stock), MPW -3.1% (announced that it has commenced an offering to sell 30 million shares of its common stock in an underwritten public offering), STML -2.1% (announced proposed public offering of common stock, size not disclosed)
Click here to read the full comment.
Portfolio Ticker Matches: WRAPX
This email was sent to you at: sgva@bloomberg.net. To ensure delivery to your Inbox and have images displayed properly, please add update@briefing.com to your Address Book or Safe Sender List.
Briefing.com sends these emails based on the preferences you set for your account. If you no longer wish to receive this email, unsubscribe here. To edit your email preferences, click here. Visit our Privacy Policy if you have any questions.
Briefing.com offers a wide range of premium services. Free trial requests can be made via our institutional sales or customer service departments.
401 N. Michigan Avenue, Suite 2910 Chicago, IL 60611
Copyright © 2015 Briefing.com, Inc. All rights reserved.
